Peregrine Capital Management LLC Lantheus Holdings, Inc. Transaction History

Peregrine Capital Management LLC

$3.31 Billion
Q2 2024

A detailed history of Peregrine Capital Management LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Peregrine Capital Management LLC holds 189,721 shares of LNTH stock, worth $20.4 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

189,721

Previous 190,372 0.34%

Holding current value

$20.4 Million

Previous $11.8 Million 28.56%

% of portfolio

0.46%

Previous 0.35%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$58.87 - $83.05 $38,324 - $54,065	-651 Reduced 0.34%	189,721 $15.2 Million
Q1 2024 Apr 26, 2024	SELL	$51.07 - $68.26 $582,657 - $778,778	-11,409 Reduced 5.65%	190,372 $11.8 Million
Q4 2023 Jan 26, 2024	SELL	$55.6 - $77.89 $3.69 Million - $5.17 Million	-66,329 Reduced 24.74%	201,781 $12.5 Million
Q3 2023 Oct 19, 2023	BUY	$60.27 - $90.75 $1.24 Million - $1.87 Million	20,554 Added 8.3%	268,110 $18.6 Million
Q2 2023 Jul 26, 2023	SELL	$82.41 - $99.65 $843,136 - $1.02 Million	-10,231 Reduced 3.97%	247,556 $20.8 Million
Q1 2023 Apr 26, 2023	SELL	$47.76 - $82.86 $565,287 - $980,730	-11,836 Reduced 4.39%	257,787 $21.3 Million
Q4 2022 Jan 10, 2023	BUY	$48.76 - $77.67 $2.8 Million - $4.45 Million	57,355 Added 27.02%	269,623 $13.7 Million
Q3 2022 Oct 26, 2022	SELL	$61.42 - $86.29 $34,886 - $49,012	-568 Reduced 0.27%	212,268 $14.9 Million
Q2 2022 Jul 20, 2022	SELL	$55.54 - $72.65 $170,007 - $222,381	-3,061 Reduced 1.42%	212,836 $14.1 Million
Q1 2022 Apr 27, 2022	SELL	$24.28 - $56.64 $11.9 Million - $27.7 Million	-489,931 Reduced 69.41%	215,897 $11.9 Million
Q4 2021 Jan 31, 2022	SELL	$22.54 - $30.44 $2.93 Million - $3.96 Million	-130,125 Reduced 15.57%	705,828 $20.4 Million
Q3 2021 Nov 02, 2021	SELL	$24.23 - $28.59 $4.18 Million - $4.93 Million	-172,376 Reduced 17.1%	835,953 $21.5 Million
Q2 2021 Aug 03, 2021	SELL	$19.51 - $27.64 $2.07 Million - $2.93 Million	-106,181 Reduced 9.53%	1,008,329 $27.9 Million
Q1 2021 May 11, 2021	SELL	$13.77 - $21.66 $547,880 - $861,808	-39,788 Reduced 3.45%	1,114,510 $23.8 Million
Q4 2020 Jan 19, 2021	BUY	$10.75 - $14.91 $6.95 Million - $9.64 Million	646,803 Added 127.45%	1,154,298 $15.6 Million
Q3 2020 Oct 20, 2020	BUY	$11.98 - $16.34 $915,487 - $1.25 Million	76,418 Added 17.73%	507,495 $6.43 Million
Q2 2020 Jul 30, 2020	BUY	$10.34 - $15.51 $63,301 - $94,952	6,122 Added 1.44%	431,077 $6.16 Million
Q1 2020 Apr 17, 2020	BUY	$9.11 - $20.05 $1.91 Million - $4.2 Million	209,454 Added 97.19%	424,955 $5.42 Million
Q4 2019 Jan 16, 2020	SELL	$18.47 - $24.03 $9,087 - $11,822	-492 Reduced 0.23%	215,501 $4.42 Million
Q3 2019 Oct 16, 2019	SELL	$21.01 - $28.94 $1.96 Million - $2.7 Million	-93,435 Reduced 30.2%	215,993 $5.41 Million
Q2 2019 Jul 18, 2019	SELL	$23.33 - $28.3 $10.2 Million - $12.4 Million	-438,269 Reduced 58.62%	309,428 $0
Q1 2019 Apr 12, 2019	SELL	$14.93 - $25.1 $1.33 Million - $2.24 Million	-89,411 Reduced 10.68%	747,697 $0
Q4 2018 Jan 17, 2019	BUY	$12.68 - $19.01 $3.42 Million - $5.12 Million	269,334 Added 47.44%	837,108 $13.1 Million
Q3 2018 Oct 18, 2018	SELL	$13.1 - $16.35 $112,293 - $140,152	-8,572 Reduced 1.49%	567,774 $0
Q2 2018 Jul 12, 2018	SELL	$13.65 - $18.7 $632,513 - $866,520	-46,338 Reduced 7.44%	576,346 $0
Q1 2018 Apr 16, 2018	BUY	$14.85 - $24.3 $3 Million - $4.92 Million	202,312 Added 48.13%	622,684 $0
Q4 2017 Jan 24, 2018	SELL	$17.4 - $23.4 $566,196 - $761,436	-32,540 Reduced 7.18%	420,372 $0
Q3 2017 Oct 25, 2017	BUY	$15.5 - $19.15 $7.02 Million - $8.67 Million	452,912	452,912 $0

Others Institutions Holding LNTH

# of Institutions

495

Shares Held

67.2M

Call Options Held

1.19M

Put Options Held

829K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.38B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Account

Peregrine Capital Management LLC Lantheus Holdings, Inc. Transaction History